Class II
Ongoing
Cinacalcet Hydrochloride Tablets, 60 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren…
Why: cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).
- Company
- Cipla USA, Inc.
Warren, NJ, United States - Reported
- Jul 8, 2026
- Recall started
- Jun 29, 2026
- Where sold
- USA Nationwide
- Amount
- N/A
- Full product description
- Cinacalcet Hydrochloride Tablets, 60 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-411-02
- Lots / codes affected
- Lot #: 5PB0165, 5PB0166, Exp 1/31/2027; 5PB0552, Exp 4/30/2027; 5PB0642, 5PB0643, 5PB0644, Exp 6/30/2027
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.